Literature DB >> 10441566

The challenges of psychopharmacogenetics.

M Catalano1.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10441566      PMCID： PMC1377966          DOI： 10.1086/302559

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  32 in total

Review 1.  Monoamine oxidase in neuropsychiatry and behavior.

Authors:  J C Shih; R F Thompson
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

2.  Non-functional CYP2D6 alleles and risk for neuroleptic-induced movement disorders in schizophrenic patients.

Authors:  O A Andreassen; T MacEwan; A K Gulbrandsen; R G McCreadie; V M Steen
Journal:  Psychopharmacology (Berl)       Date:  1997-05       Impact factor: 4.530

3.  Association between clozapine response and allelic variation in the 5-HT2C receptor gene.

Authors:  M S Sodhi; M J Arranz; D Curtis; D M Ball; P Sham; G W Roberts; J Price; D A Collier; R W Kerwin
Journal:  Neuroreport       Date:  1995-12-29       Impact factor: 1.837

Review 4.  Ethnicity and pharmacogenetics.

Authors:  M W Smith; R P Mendoza
Journal:  Mt Sinai J Med       Date:  1996 Oct-Nov

5.  Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor gene.

Authors:  M Rietschel; D Naber; H Oberländer; R Holzbach; R Fimmers; K Eggermann; H J Möller; P Propping; M M Nöthen
Journal:  Neuropsychopharmacology       Date:  1996-11       Impact factor: 7.853

6.  Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region.

Authors:  K P Lesch; D Bengel; A Heils; S Z Sabol; B D Greenberg; S Petri; J Benjamin; C R Müller; D H Hamer; D L Murphy
Journal:  Science       Date:  1996-11-29       Impact factor: 47.728

7.  Antipsychotic drug-induced movement disorders in schizophrenics in relation to CYP2D6 genotype.

Authors:  M Armstrong; A K Daly; R Blennerhassett; N Ferrier; J R Idle
Journal:  Br J Psychiatry       Date:  1997-01       Impact factor: 9.319

8.  Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine.

Authors:  A K Malhotra; D Goldman; N Ozaki; A Breier; R Buchanan; D Pickar
Journal:  Am J Psychiatry       Date:  1996-08       Impact factor: 18.112

Review 9.  An overview of the mechanism of action of clozapine.

Authors:  H Y Meltzer
Journal:  J Clin Psychiatry       Date:  1994-09       Impact factor: 4.384

10.  Allelic variation of human serotonin transporter gene expression.

Authors:  A Heils; A Teufel; S Petri; G Stöber; P Riederer; D Bengel; K P Lesch
Journal:  J Neurochem       Date:  1996-06       Impact factor: 5.372
View more
  7 in total

Review 1.  Genetic studies of alcoholism and substance dependence.

Authors:  T Reich; A Hinrichs; R Culverhouse; L Bierut
Journal:  Am J Hum Genet       Date:  1999-09       Impact factor: 11.025

2.  Quantitative trait loci for the monoamine-related traits heart rate and headless behavior in Drosophila melanogaster.

Authors:  K Ashton; A P Wagoner; R Carrillo; G Gibson
Journal:  Genetics       Date:  2001-01       Impact factor: 4.562

Review 3.  Genetic animal models of anxiety.

Authors:  Deborah A Finn; Mark T Rutledge-Gorman; John C Crabbe
Journal:  Neurogenetics       Date:  2003-03-29       Impact factor: 2.660

Review 4.  Pharmacogenetics of bipolar disorder.

Authors:  Hader A Mansour; Martin Alda; Vishwajit L Nimgaonkar
Journal:  Curr Psychiatry Rep       Date:  2002-04       Impact factor: 5.285

Review 5.  Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.

Authors:  Katherine I Morley; Wayne D Hall
Journal:  J Mol Med (Berl)       Date:  2003-11-04       Impact factor: 4.599

6.  Pathophysiology of depression and mechanisms of treatment.

Authors:  Bondy Brigitta
Journal:  Dialogues Clin Neurosci       Date:  2002-03       Impact factor: 5.986

7.  Candidate genes for antidepressant response to selective serotonin reuptake inhibitors.

Authors:  Francis E Lotrich; Bruce G Pollock
Journal:  Neuropsychiatr Dis Treat       Date:  2005-03       Impact factor: 2.570
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.